Updated October 13, 2025
The original link broke.
You can still read about the same topic here:
--- the original post follows below ---
The Effect of COVID-19 on NABP’s Drug Distributor Accreditation Program (formerly VAWD) & The Future of Accreditation and Re-accreditation - GTC Consulting
According to the post:
" ... applicants pursuing the National Association of Boards of Pharmacy (NABP) Drug Distributor Accreditation (formerly the Verified Accredited Wholesale Distributor program or VAWD) are not being cleared for survey unless the applicants sufficiently prove they have a process in place to detect and prevent the spread of COVID-19. I think we can all agree from a public health perspective this makes sense. However, the challenge here, as everyone who has ever been through this accreditation process is well aware of, NABP is not the best at providing clear guidance as to what they specifically want from the applicant to satisfy their standards. This new requirement is no exception as many applicants find themselves going back and forth with NABP hoping to mitigate costly and time consuming survey delays."
Return Home: The Designated Representative and Exemptee Blog
-------------
For Designated Representative license applicants - Training programs, courses, classes, seminars:
California (earn a training affidavit):- CA Designated Representative Wholesaler Training - Available around-the-clock 24 x 7
- CA Designated Representative 3PL Training
- CA Designated Representative Reverse Distributor Training
- The Designated Representative Institute
